Member Info for crumbs

'Our current vaccines have not yet been studied against this variant. We are working to understand what impact it might have, but we do know that the variant has caused significant challenges in Brazil, so we are doing all we can to stop the spread of this new variant in the UK, to analyse its effects, to develop an updated vaccine that works ON ALL THESE variants of concern, and to protect the progress that we have made as a nation. This country is on the road to recovery and we have freedom on the horizon. We must proceed with caution because although we are moving quickly, the virus moves quickly too. Let us not waver. Let us do whatever it takes to keep this virus under control.'
Published 2 March 2021

Ok might be wrong on this that sounds like a 'universal vaccine' like Covidity but I suppose the word 'updated' kinda means the current ones tweaked... anyways there is a need and Covidity is on the radar so......

And I wouldn't want to be out of this ATM!...market never lies blah blah

roses that is one thing I am not worried about lol

Well where ever it parks I hope it doesn't get clamped and towed away

I do think the Vox vid was somehow redmile related via the turner pope connection and well they get a lot of mentions and praise in it! And that it has been getting US viewers just from times of when the viewing figures went up...

Confirmation came through that the new Nottingham Labs are not made of cardboard

It'll be the Chelsea Cross :)

It'll be the Chelsea Cross :)

Sorry the inovio vax that they are working with is not a covid one!... they do have one though ... a bit of a troubled one

BTW CEPI are not new to DNA covid vaxs they already work with our old mates inovio ....
https://cepi.net/news_cepi/cepi-partner-inovio-launches-lassa-vaccine-phase-i-trial-in-west-africa/

If there is indeed something brewing with CEPI it could open up all kinds of possibilities with where Covidity could possibly be trialled etc... anyways, for now, nice to have the recognition and well-done boom for your tweeting work too... notice scancell retweeted both yours and then official CEPI tweet... but theirs is already getting the inovio investor treatment lol

Totally agree there.... we are on or at least getting on the right radars and the virus is doing its bit too

Ray, I think the notts delivery will come in house too making ImmunoBody a completely new package ... fits with what Cliff said in the presentation

Always best to go after more than just the spike :)

C7
What has changed?? Nothing, except CH never told us to pile in this week for news, well he was never going to was he??
quite.. what has changed is more sellers than buyers hasibos is prime example the shares he is selling are in a company that is just in the same position as the ones he bought into just he made a profit .... so no need for all the other guffins ... cardboad labs indeed pfft

Chester, you're right about that intriguing slide... though as far as we know via RNS SN14 is chosen and the one undergoing manufacture... obviously lots going on trying to find our niche in the current vaccine sphere... Cliff mentions Covidity being a 'booster'....
I reckon a lot is going to be down to who is showing an interest and what their interest is...

'Both Norway and Germany are long-term partners and two of the biggest investors in CEPI’s work. Norway was one of CEPI’s founding members when the organisation launched, in the wake of the 2014-16 Ebola epidemic, as the result of a consensus that a coordinated, international, and intergovernmental plan was needed to develop and deploy new vaccines to prevent future epidemics. The Government of Germany also provided significant financial contributions to advance CEPI’s mission in 2017 through the German Federal Minister of Education and Research (Bundesministerium für Bildung und Forschung; BMBF) and again in 2020 to support the establishment of CEPI’s COVID-19 vaccine portfolio.

The new funding will support CEPI’s goal of raising $1 billion in 2021 to carry out critical R&D to future-proof vaccines against emerging variants, maximise the available supply of vaccines, and fill in current clinical research and development gaps to optimise the use of the vaccines we have.'

of course 'future proof' is no guarantee of past share price performance :)

Brilliant ....Not just on the next-gen vax map but a recognised landmark...

'CEPI is an innovative global partnership between public, private, philanthropic, and civil society organisations launched in Davos in 2017 to develop vaccines to stop future epidemics.

Our mission is to accelerate the development of vaccines against emerging infectious diseases and enable equitable access to these vaccines for people during outbreaks.'

'Many organisations operate within the end-to-end space of vaccine funding and R&D implementation. However, a number of critical gaps have been identified, which CEPI was designed to fill.

First, CEPI will advance vaccines against known threats through proof-of-concept and safety testing in humans and will establish investigational vaccine stockpiles before epidemics begin—”just in case”.

Second, we will fund new and innovative platform technologies with the potential to accelerate the development and manufacture of vaccines against previously unknown pathogens (eg: within 16 weeks from identification of antigen to product release for clinical trials)—”just in time”.

Third, CEPI will support and coordinate activities to improve our collective response to epidemics, strengthen capacity in countries at risk, and advance the regulatory science that governs product development.'

I have no problem with buyers either both new and old :)

At least we have an ally with media power.....

If ever there was a spur this is it.. couldn't be timed better for covidityl... schools are back next week... if these variants are out there in low numbers at the moment they will soon be in high numbers and if the current vaccines show limited efficiency we will be looking at lockdown again... so better to push for insurance and the way of that is next gen vaxs get fast tracked